Kenvue Inc.
One of the world's largest pure-play consumer health companies, Kenvue makes everyday brands most people already know — Tylenol and Zyrtec for self-care, Neutrogena and Aveeno for skin, and Listerine and BAND-AID for everyday essentials — sold in more than 165 countries. It was spun off from Johnson & Johnson in 2023, and its name blends a Scottish word meaning "knowledge" with "view," chosen to suggest deep consumer insight. The name is pronounced "ken-view."
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| FMR LLC | 13G/APassive | 8.2% | 157.05M | Aug 6, 2026 |
| Abigail P. Johnson | 13G/APassive | 8.2% | 157.05M | Aug 6, 2026 |
| Vanguard Capital Management | 13GPassive | 7.5% | 143.92M | Apr 30, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 27, 2026 |
| T. Rowe Price Associates, Inc. | 13G/APassive | 1% | 19.75M | Feb 17, 2026 |
| Massachusetts Financial Services Company | 13G/APassive | 4.8% | 91.22M | Aug 4, 2025 |